pigmentation
N |
• compound heterozygous mice that develop in the absence of doxycycline (dox) (Ednrb is expressed) are fully pigmented and viable
• all, but one, compound heterozygotes born to females given dox (Ednrb expression is repressed) after E12.5 or E13.5 are normal and do not develop megacolon
|
• compound heterozygous mice that develop in the presence of dox throughout pregnancy (no expression of Ednrb) display a piebald-lethal phenotype
• all compound heterozygotes born to mothers given dox at E10.5, display the full piebald-lethal phenotype
• about 50% of compound heterozygotes born to females given dox after E11.5 are piebald-lethal, with the rest pigmented in the rostral one- to two-thirds of the body and develop megacolon
|
digestive/alimentary system
N |
• all, but one, compound heterozygotes born to females given dox (no expression of Ednrb) after E12.5 or E13.5 are normal and do not develop megacolon
|
• about 50% of compound heterozygotes born to females given dox at E11.5 develop megacolon
|
nervous system
• compound heterozygotes born to females given dox between E11.5 and E12.5 exhibit no neuroblasts beyond the coecum
|
integument
• compound heterozygous mice that develop in the presence of dox throughout pregnancy (no expression of Ednrb) display a piebald-lethal phenotype
• all compound heterozygotes born to mothers given dox at E10.5, display the full piebald-lethal phenotype
• about 50% of compound heterozygotes born to females given dox after E11.5 are piebald-lethal, with the rest pigmented in the rostral one- to two-thirds of the body and develop megacolon
|